Surgical Laser for Early Glottic Cancer

Early glottic cancer (Tis, T1a, T1b, T2) is one of the most treatable head and neck cancers. Not only does hoarseness enable for an early diagnosis, but due to the glottis’ unique lymphatic outflow, less than 1% of individuals acquire cervical metastases.

Laser surgery, as an alternate treatment for early glottic cancer, provides the highest level of oncologic radicality. The overall survival rate approached 90%.

This can only indicate that employing laser therapy with expert and effective laser devices will almost certainly ensure full and speedy healing.

The  FDA Portable Surgery Diode Laser System LASER-1.2B. presents itself as one of the most recommended devices among surgeons viewing its high-efficacy in treating such type of cancer.

This device’s blue laser light interacts better with the tissue components haemoglobin or melanin. At 980 nm, the machine performs better and gentler cutting, even at lower power.

As a result of its better cutting capability, it’s appropriate for all surgical applications, especially early glottic malignancy.

The LASER-1.2B is also highly recommended by surgical oncologists because it provides precise alignment and sighting during treatment. Its green targeting laser is to thank for this.

To further improve the treatment, the device is supported with a fibre guide laser. So, it is compatible with various endoscopic uses. Also, these special fibres are sterilisable which, in turn, prevents any possible cross-infection while guaranteeing a clean and bloodless operative area.

With a wavelength of 980 nm and a maximum power of 15W, the device is anticipated to be ideal for very sensitive procedures in early-stage Glottic cancer.

That is highly attributed to the fact that The LASER-1.2B uses infrared wavelengths and ultra-blue light to ensure high-level performance.

That is also estimated to reduce the thermal damage and to its peculiar interaction with haemoglobin.

All of these properties ensure that the LASER-1.2B’s cutting efficacy is significantly higher than that of infrared lasers.

Since their invention, laser use and applications have expanded rapidly as it proved to be a successful addition to cancer surgery.  

The benefits of laser treatment are discussed in this article, as well as the efficacy of the LASER-1.2B as a surgical laser device in treating Early Glottic Cancer.

Reference: Laser surgery for early glottic cancer: impact of margin status on local control and organ preservation

Disclaimer: Although the information we provide is used by different doctors and medical staff to perform their procedures and clinical applications, the information contained in this article is for consideration only. SIFLASER is not responsible neither for the misuse of the device nor for the wrong or random generalizability of the device in all clinical applications or procedures mentioned in our articles. Users must have the proper training and skills to perform the procedure with each vein finder device.

The products mentioned in this article are only for sale to medical staff (doctors, nurses, certified practitioners, etc.) or to private users assisted by or under the supervision of a medical professional.